Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TENOR: Tocilizumab in Polymyalgia Rheumatica
NCT01713842Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jul 2012
- Primary completion
- Oct 2014
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in polymyalgia rheumatica (PMR), sponsored by Centre Hospitalier Universitaire de Brest. Started Jul 2012; status: completed.
02
Drugs
tocilizumab
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT01713842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713842.